G

Genus

Global animal genetics and breeding technology

Production Manager - Boar Stud Operations

Full-TimeDeadline 10/4/27
$55k - $70k/yr
Mid
Bachelor's
Mound City, SD, USA
In Person
Manufacturing & Production Operations

About the job

Requirements
  • A minimum of a high school diploma is required.
  • A minimum of three years of experience within contemporary swine production systems or Gene Transfer Center operations, with proven results, is required.
  • Proven experience working with culturally diverse teams in a fast-paced environment is required.
  • Ability to establish priorities, meet deadlines, and maintain accuracy is required.
  • Strong communication, interpersonal, and organizational skills are required.
  • Ability to analyze and solve problems in a production environment is required.
  • Proficiency in Microsoft Office and other relevant software applications, and ability to learn new software programs, is required.
  • Ability to train and develop employees is required.
  • Commitment to teamwork and continuous improvement is required.
  • Willingness to shower daily in and out of the facility and follow strict biosecurity procedures is required.
  • Ability to work weekends, evenings, holidays, and emergency situations as needed is required.
  • Ability to perform physical labor in a production environment is required.
  • Ability to travel approximately 5–10% is required.
Responsibilities
  • Achieve weekly, monthly, and annual key performance indicators, budgets, and production goals.
  • Manage the daily schedule of semen collection and processing activities.
  • Coordinate accurate fulfillment of internal and external semen orders, including domestic and export orders.
  • Train staff and onboard new employees.
  • Execute health management programs and health reporting functions across the area of responsibility.
  • Coordinate herd health testing and monitoring, and health paperwork for export semen orders.
  • Treat sick animals according to PIC Health Assurance guidelines.
  • Fulfill prioritized semen orders from genetically elite sires for multiple mating strategies and sire lines, as directed by PIC Genetic Services.
  • Execute feeding practices, order feed on time, and maintain proper sire body condition.
  • Maintain accurate records in Prism and PICTraq databases.
  • Produce accurate production information and update department records as required.
  • Implement evolving standard operating procedures.
  • Order supplies, control inventory, and maintain specialized equipment and technologies.
  • Direct and prioritize maintenance personnel in relation to their allocated time in the department.
  • Assist with maintaining cleanliness of the barn, laboratory, office, and employee areas, with particular attention to laboratory hygiene.
  • Ensure compliance with genetic improvement, biosecurity, animal welfare, and safety programs; identify variances and outline action plans to restore compliance.
  • Follow animal care policies and procedures, including providing an appropriate physical environment, adequate water and high-quality feed, humane treatment, appropriate health care, and proper euthanasia procedures.
  • Provide employee reviews and performance assessments in line with corporate strategy and provide input on employee merit.
  • Comply with environmental laws and procedures and immediately report environmental issues to a supervisor.
  • Ensure staff understand the company emergency notification process and its application to their worksite.
  • Ensure staff understand job safety requirements and perform work in compliance with them.
  • Communicate with teammates, interdependent departments, and supervisors to achieve goals.
  • Perform other assigned duties necessary for the care of the sires, facility, and semen production process.
Desired Qualifications
  • A college degree is preferred.
  • Previous boar stud or semen processing experience is preferred.
  • Bilingual proficiency in English and Spanish is preferred.

About the company

Genus is a global animal-genetics company focused on improving cattle and pig performance through breeding and genetic technologies. It operates two main units, ABS Global for bovine genetics and PIC for porcine genetics, offering breeding animals, reproduction services, and gene-editing and next-generation breeding tools. Its products work by combining genetics, reproductive biology, and data-driven selection to produce healthier herds, higher-quality food, and more efficient production. Genus differentiates itself through its global scale (operations in 30 countries and distribution to over 50 markets), its specialized units for cattle and pigs, and its integration of science with practical farming solutions. Its goal is to sustainably nourish the world by improving animal health, food quality, and the resilience of the global food system, while delivering value to customers and upholding ethical, collaborative values.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Basingstoke, United Kingdom

Founded

1933

Get referred to Genus

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Genus said 14 July 2026 FY26 results should beat consensus and cut leverage.
  • The Chinese porcine joint venture delivered about £111 million cash in FY26.
  • ABS posted double-digit profit growth in FY26, helped by the Value Acceleration Programme.

What critics are saying

  • North American PIC volumes weakened in FY26 from customer disease challenges.
  • Genus still depends on further approvals before selling PRRS-resistant pigs in Canada.
  • If EU and U.S. adoption stalls, PRRS-resistant pigs stay a stranded platform.

What makes Genus unique

  • PIC’s PRRS-resistant pigs won Canada approval on 23 January 2026.
  • Genus monetizes elite genetics through recurring royalties, not commodity livestock sales.
  • ABS and PIC combine bovine and porcine genetics across 100-plus countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Parental Leave
  • Employee Stock Purchase Plan
  • Paid Holidays
  • Paid Vacation

Company News

Associated Press
Jan 23rd, 2026
Canada approves PRRSV-resistant pigs for food and feed to cut farm losses and antibiotic use

Canada has approved genetically engineered pigs resistant to porcine reproductive and respiratory syndrome viruses for use in food and feed. Health Canada and the Canadian Food Inspection Agency completed independent safety assessments following applications from Genus PLC and PIC Canada, concluding the pigs are as safe and nutritious as conventional pork. The approval addresses PRRSV, one of the most devastating virus classes affecting farmed pigs, which causes severe symptoms including breathing problems, fever and stillborn piglets. There are currently no effective treatments available. Genus PLC's PRRSV-resistant pigs are already approved in the US, Brazil, Colombia and the Dominican Republic. However, the company will not sell these pigs in Canada until receiving regulatory authorisation in other key markets. Canada's swine industry generated over $6.3 billion in farm cash receipts in 2024.

TipRanks
Oct 21st, 2024
Genus plc CFO to Retire, Successor Search Underway

Genus plc, a global leader in animal genetics, has announced the upcoming retirement of its Chief Financial Officer, Alison Henriksen, who will leave her role in July 2025 after five years with the company.

PharmiWeb
Sep 7th, 2023
Genus Plc Preliminary Results For The Year Ended 30 June 2023

SOLID PERFORMANCE AND GOOD STRATEGIC PROGRESSWEBCAST AVAILABLE AT 7:01AM GMT, 2.01 ESTLONDON--(BUSINESS WIRE)--Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2023. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 EST.Commenting on the performance and outlook, Jorgen Kokke, Chief Executive Officer, said:“The Group achieved a strong operational performance despite ongoing challenging market conditions for producers in several important markets. Revenues grew in all regions and both PIC and ABS delivered profit growth. This also enabled us to deliver record adjusted EBITDA and good cashflow for the Group. Growth in R&D investments, primarily due to the strategically important gene editing work and expansion of PIC’s elite farms, as well as higher interest costs, resulted in adjusted profit before tax consistent with the prior year.“PIC’s performance was particularly impressive, achieving a record adjusted operating profit for the year

MarketWatch
Apr 3rd, 2023
Genus Names Jorgen Kokke as Chief Executive Officer Designate

Genus PLC said Monday that it has appointed Jorgen Kokke as chief executive officer designate, effective from May 2.

PharmiWeb
Sep 8th, 2022
Genus Plc Reports Preliminary Results For The Year Ended 30 June 2022

Continued Strategic Progress in Challenging Markets. Webcast Available at 7:01AM BST, 2.01 EDT